Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
TSE:4506
Price:
591
JPY
-6.49%
Market Closed
Market Cap:
234.8B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Sumitomo Pharma Co Ltd
591
-41 (-6.49%)
| 52 Week Range |
285
684
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sumitomo Pharma Co Ltd
Income Statement
Earnings Waterfall
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
|
Revenue
|
329.5B
JPY
|
|
Cost of Revenue
|
-131.1B
JPY
|
|
Gross Profit
|
198.5B
JPY
|
|
Operating Expenses
|
-504.8B
JPY
|
|
Operating Income
|
-306.4B
JPY
|
|
Other Expenses
|
46.2B
JPY
|
|
Net Income
|
-260.2B
JPY
|
Income Statement
Sumitomo Pharma Co Ltd
Sumitomo Pharma Co Ltd
Currency: JPY
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
387 814
N/A
|
384 587
-1%
|
382 317
-1%
|
371 370
-3%
|
379 755
+2%
|
392 006
+3%
|
396 763
+1%
|
403 206
+2%
|
408 566
+1%
|
402 368
-2%
|
404 181
+0%
|
408 357
+1%
|
421 036
+3%
|
441 620
+5%
|
458 005
+4%
|
466 838
+2%
|
466 582
0%
|
461 642
-1%
|
458 554
-1%
|
459 267
+0%
|
460 840
+0%
|
463 715
+1%
|
469 413
+1%
|
482 732
+3%
|
499 105
+3%
|
513 627
+3%
|
520 477
+1%
|
515 952
-1%
|
513 291
-1%
|
548 184
+7%
|
553 262
+1%
|
560 035
+1%
|
588 715
+5%
|
585 594
-1%
|
588 228
+0%
|
555 544
-6%
|
471 354
-15%
|
388 897
-17%
|
330 307
-15%
|
314 558
-5%
|
329 547
+5%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(102 932)
|
(102 136)
|
(101 084)
|
(101 227)
|
(103 486)
|
(104 843)
|
(105 194)
|
(104 470)
|
(102 055)
|
(100 274)
|
(99 749)
|
(94 625)
|
(98 177)
|
(103 744)
|
(108 708)
|
(112 345)
|
(113 776)
|
(110 929)
|
(109 100)
|
(113 553)
|
(113 594)
|
(114 246)
|
(121 714)
|
(129 045)
|
(136 690)
|
(144 081)
|
(141 126)
|
(137 645)
|
(140 279)
|
(143 933)
|
(150 813)
|
(157 116)
|
(164 707)
|
(173 114)
|
(179 058)
|
(178 494)
|
(163 293)
|
(146 401)
|
(132 343)
|
(126 528)
|
(131 096)
|
|
| Gross Profit |
284 882
N/A
|
282 451
-1%
|
281 233
0%
|
270 143
-4%
|
276 269
+2%
|
287 163
+4%
|
291 569
+2%
|
298 736
+2%
|
306 511
+3%
|
302 094
-1%
|
304 432
+1%
|
313 732
+3%
|
322 859
+3%
|
337 876
+5%
|
349 297
+3%
|
354 493
+1%
|
352 806
0%
|
350 713
-1%
|
349 454
0%
|
345 714
-1%
|
347 246
+0%
|
349 469
+1%
|
347 699
-1%
|
353 687
+2%
|
362 415
+2%
|
369 546
+2%
|
379 351
+3%
|
378 307
0%
|
373 012
-1%
|
404 251
+8%
|
402 449
0%
|
402 919
+0%
|
424 008
+5%
|
412 480
-3%
|
409 170
-1%
|
377 050
-8%
|
308 061
-18%
|
242 496
-21%
|
197 964
-18%
|
188 030
-5%
|
198 451
+6%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(243 074)
|
(245 799)
|
(250 925)
|
(246 868)
|
(257 246)
|
(258 986)
|
(260 026)
|
(261 807)
|
(260 481)
|
(255 281)
|
(254 348)
|
(263 671)
|
(265 498)
|
(254 854)
|
(272 359)
|
(260 780)
|
(280 449)
|
(292 408)
|
(283 562)
|
(281 018)
|
(264 753)
|
(254 357)
|
(255 185)
|
(235 569)
|
(296 328)
|
(305 603)
|
(290 037)
|
(288 288)
|
(316 753)
|
(332 994)
|
(360 533)
|
(342 940)
|
(357 466)
|
(374 363)
|
(368 961)
|
(431 192)
|
(413 047)
|
(393 317)
|
(392 780)
|
(361 778)
|
(504 848)
|
|
| Selling, General & Administrative |
(172 749)
|
(174 323)
|
(178 900)
|
(170 434)
|
(181 033)
|
(180 640)
|
(180 954)
|
(174 052)
|
(178 220)
|
(175 718)
|
(174 107)
|
(165 564)
|
(165 169)
|
(171 262)
|
(183 057)
|
(181 384)
|
(196 756)
|
(199 368)
|
(193 988)
|
(178 285)
|
(158 076)
|
(128 453)
|
(128 782)
|
(179 448)
|
(175 473)
|
(201 491)
|
(203 567)
|
(195 978)
|
(203 422)
|
(220 873)
|
(232 383)
|
(220 620)
|
(264 231)
|
(279 175)
|
(294 707)
|
(283 474)
|
(318 303)
|
(299 860)
|
(277 682)
|
(225 882)
|
(398 481)
|
|
| Research & Development |
(70 331)
|
(71 481)
|
(72 026)
|
(71 304)
|
(76 198)
|
(78 336)
|
(79 064)
|
0
|
(81 264)
|
(79 577)
|
(80 247)
|
(81 373)
|
(81 909)
|
(83 914)
|
(87 268)
|
(86 928)
|
(87 917)
|
(87 965)
|
(85 835)
|
(102 364)
|
(101 556)
|
(121 193)
|
(124 091)
|
(92 646)
|
(120 800)
|
(104 167)
|
0
|
(97 241)
|
(106 903)
|
(106 718)
|
(128 794)
|
(94 903)
|
(96 896)
|
(99 177)
|
(103 117)
|
(131 858)
|
(135 280)
|
(132 234)
|
(129 509)
|
(102 060)
|
(97 917)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(5 129)
|
0
|
0
|
0
|
(5 720)
|
0
|
0
|
0
|
(5 821)
|
0
|
0
|
0
|
(6 538)
|
0
|
0
|
0
|
(7 858)
|
0
|
0
|
0
|
(11 272)
|
0
|
0
|
0
|
(16 707)
|
0
|
0
|
0
|
(31 742)
|
0
|
0
|
0
|
(34 104)
|
0
|
0
|
0
|
(31 833)
|
0
|
|
| Other Operating Expenses |
6
|
5
|
1
|
(1)
|
(15)
|
(10)
|
(8)
|
(82 035)
|
(997)
|
14
|
6
|
(10 913)
|
(18 420)
|
322
|
(2 034)
|
14 070
|
4 224
|
(5 075)
|
(3 739)
|
7 489
|
(5 121)
|
(4 711)
|
(2 312)
|
47 797
|
(55)
|
55
|
(86 470)
|
21 638
|
(6 428)
|
(5 403)
|
644
|
4 325
|
3 661
|
3 989
|
28 863
|
18 244
|
40 536
|
38 777
|
14 411
|
(2 003)
|
(8 450)
|
|
| Operating Income |
41 808
N/A
|
36 652
-12%
|
30 308
-17%
|
23 275
-23%
|
19 023
-18%
|
28 177
+48%
|
31 543
+12%
|
36 929
+17%
|
46 030
+25%
|
46 813
+2%
|
50 084
+7%
|
50 061
0%
|
57 361
+15%
|
83 022
+45%
|
76 938
-7%
|
93 713
+22%
|
72 357
-23%
|
58 305
-19%
|
65 892
+13%
|
64 696
-2%
|
82 493
+28%
|
95 112
+15%
|
92 514
-3%
|
118 118
+28%
|
66 087
-44%
|
63 943
-3%
|
89 314
+40%
|
90 019
+1%
|
56 259
-38%
|
71 257
+27%
|
41 916
-41%
|
59 979
+43%
|
66 542
+11%
|
38 117
-43%
|
40 209
+5%
|
(54 142)
N/A
|
(104 986)
-94%
|
(150 821)
-44%
|
(194 816)
-29%
|
(173 748)
+11%
|
(306 397)
-76%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
3 307
|
941
|
99
|
1 630
|
7 359
|
7 844
|
8 590
|
5 146
|
(3 011)
|
(837)
|
5 309
|
2 495
|
4 625
|
2 813
|
(2 019)
|
(3 307)
|
1 136
|
3 183
|
157
|
7 162
|
(1 170)
|
(3 518)
|
3 792
|
708
|
2 931
|
(489)
|
(10 064)
|
6 627
|
7 570
|
12 206
|
21 793
|
22 727
|
55 072
|
70 982
|
35 341
|
29 059
|
17 578
|
9 481
|
21 644
|
25 631
|
31 538
|
|
| Non-Reccuring Items |
(6 111)
|
(2 418)
|
(7 567)
|
(5 560)
|
(7 297)
|
(6 779)
|
(1 618)
|
(1 165)
|
0
|
(11 003)
|
(10 891)
|
(9 775)
|
0
|
0
|
0
|
(5 540)
|
0
|
0
|
(1 789)
|
(6 812)
|
0
|
0
|
0
|
(34 879)
|
0
|
0
|
0
|
(18 795)
|
0
|
0
|
0
|
255
|
0
|
(54 370)
|
(55 980)
|
(22 837)
|
(38 174)
|
16 259
|
17 869
|
(174 997)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
8 278
|
15 978
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1 651)
|
(1 651)
|
(1 601)
|
14 410
|
14 112
|
5 884
|
(2 099)
|
(1 350)
|
(1 350)
|
(1 147)
|
2 806
|
0
|
114
|
232
|
(3 055)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
37 353
N/A
|
41 802
+12%
|
37 217
-11%
|
33 755
-9%
|
33 197
-2%
|
35 126
+6%
|
36 416
+4%
|
39 560
+9%
|
41 669
+5%
|
33 826
-19%
|
47 308
+40%
|
42 781
-10%
|
62 100
+45%
|
86 067
+39%
|
71 864
-17%
|
84 866
+18%
|
73 493
-13%
|
61 488
-16%
|
64 260
+5%
|
65 046
+1%
|
81 323
+25%
|
91 594
+13%
|
96 306
+5%
|
83 947
-13%
|
69 018
-18%
|
63 454
-8%
|
79 250
+25%
|
77 851
-2%
|
63 829
-18%
|
83 463
+31%
|
63 709
-24%
|
82 961
+30%
|
121 614
+47%
|
54 729
-55%
|
19 570
-64%
|
(47 920)
N/A
|
(125 582)
-162%
|
(125 081)
+0%
|
(155 303)
-24%
|
(323 114)
-108%
|
(274 859)
+15%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(16 345)
|
(18 681)
|
(17 321)
|
(18 307)
|
(17 564)
|
(18 221)
|
(16 615)
|
(14 863)
|
(14 546)
|
(11 422)
|
(16 385)
|
(11 465)
|
(14 529)
|
(20 338)
|
(26 228)
|
(31 418)
|
(29 420)
|
(25 506)
|
(14 735)
|
(16 419)
|
(41 240)
|
(40 506)
|
(43 669)
|
(48 029)
|
(24 237)
|
(27 527)
|
(29 403)
|
(41 022)
|
(41 759)
|
(46 986)
|
(49 605)
|
(42 361)
|
(53 730)
|
(59 359)
|
(46 780)
|
(48 794)
|
(38 085)
|
(24 126)
|
(26 483)
|
8 185
|
14 728
|
|
| Income from Continuing Operations |
21 008
|
23 121
|
19 896
|
15 448
|
15 633
|
16 905
|
19 801
|
24 697
|
27 123
|
22 404
|
30 923
|
31 316
|
47 571
|
65 729
|
45 636
|
53 448
|
44 073
|
35 982
|
49 525
|
48 627
|
40 083
|
51 088
|
52 637
|
35 918
|
44 781
|
35 927
|
49 847
|
36 829
|
22 070
|
36 477
|
14 104
|
40 600
|
67 884
|
(4 630)
|
(27 210)
|
(96 714)
|
(163 667)
|
(149 207)
|
(181 786)
|
(314 929)
|
(260 131)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 835
|
7 528
|
11 793
|
17 184
|
19 390
|
20 692
|
18 895
|
18 217
|
15 813
|
14 835
|
17 310
|
18 762
|
22 202
|
19 182
|
14 237
|
8 068
|
(40)
|
(36)
|
|
| Net Income (Common) |
21 007
N/A
|
23 121
+10%
|
19 895
-14%
|
15 447
-22%
|
15 632
+1%
|
16 903
+8%
|
19 799
+17%
|
24 697
+25%
|
27 122
+10%
|
22 405
-17%
|
30 923
+38%
|
31 316
+1%
|
47 572
+52%
|
65 729
+38%
|
45 637
-31%
|
53 448
+17%
|
44 073
-18%
|
35 982
-18%
|
49 525
+38%
|
48 627
-2%
|
40 083
-18%
|
51 088
+27%
|
52 637
+3%
|
40 753
-23%
|
52 309
+28%
|
47 720
-9%
|
67 031
+40%
|
56 219
-16%
|
42 762
-24%
|
55 372
+29%
|
32 321
-42%
|
56 413
+75%
|
82 719
+47%
|
12 680
-85%
|
(8 448)
N/A
|
(74 512)
-782%
|
(144 485)
-94%
|
(134 970)
+7%
|
(173 718)
-29%
|
(314 969)
-81%
|
(260 167)
+17%
|
|
| EPS (Diluted) |
52.91
N/A
|
58.23
+10%
|
50.11
-14%
|
38.88
-22%
|
39.37
+1%
|
42.57
+8%
|
49.87
+17%
|
62.16
+25%
|
68.31
+10%
|
56.43
-17%
|
77.89
+38%
|
78.82
+1%
|
119.82
+52%
|
165.56
+38%
|
114.95
-31%
|
134.53
+17%
|
111.01
-17%
|
90.63
-18%
|
124.66
+38%
|
122.39
-2%
|
100.89
-18%
|
128.59
+27%
|
132.49
+3%
|
102.58
-23%
|
131.66
+28%
|
120.11
-9%
|
168.72
+40%
|
141.5
-16%
|
107.63
-24%
|
139.37
+29%
|
81.35
-42%
|
141.99
+75%
|
208.2
+47%
|
31.91
-85%
|
-21.27
N/A
|
-187.55
-782%
|
-363.67
-94%
|
-339.73
+7%
|
-437.26
-29%
|
-792.79
-81%
|
-654.85
+17%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
